Objective 17
We performed a retrospective cohort study of consecutive patients with laboratory-confirmed H1N1 influenza 87 infections, all of whom were children <5 years old who were hospitalized or received outpatient care from a 88 tertiary-care hospital in Canton, China between 1 January 2012 and 1 September 2017. Demographic and clinical 89 characteristics, including age, gender, weight, diagnoses, total length of hospital stay, intensive care unit (ICU) 90 admission, total length of ICU stay, total cost and in-hospital mortality were recorded. Data from initial laboratory 91 exams, including serum PCT and CRP levels, WBC counts, and blood and sputum cultures were collected. The ethics committee of Guangzhou Woman and Children's Medical Center approved our study, and written informed 93 consent was obtained from all the participants' parents or designated guardians. hospitalization. We selected patients for this study who did not receive antibiotics prior to hospitalization to better 102 differentiate patients co-infected with H1N1 and bacteria from patients infected with H1N1 alone. rank sum test (for continuous variables) was employed for between-group comparisons. Univariate logistic 116 regression analysis was used to assess the ability of each biomarker (PCT, CRP and WBC) to diagnose bacterial 117 co-infections. Furthermore, iterative biomarker(s) were selected (including biomarker with p<0.10) using 118 automatic forwards stepwise regression, and the multivariate logistic regression model was built. The performance 119 of the models was then assessed by calculating the area under the receiver-operating characteristic (ROC) 120 curve(AUC). The AUC values were compared for each biomarkers individually and in conjunction with and negative predictive value (NPV) were also reported. The Youden index (sensitivity + specificy-1) was used to 123 determine the optimal ROC cutoff value. Moreover, 10-fold cross-validation to evaluate the robustness of the 124 estimates obtained from the constructed model, as previously described [20] , was performed. Then, we averaged 125 the AUC, sensitivity and specificity values obtained from the 10-fold cross-validations to generate summary 126 performance estimates.
127
All statistical analyses were performed using R Software, version 3.4.2 (www.r-project.org). A two-tailed p value 128 <0.05 was considered significant.
130

Results
131
Study population and bacterial pathogen characteristics
132
During the study period, 3180 children with laboratory-confirmed H1N1 influenza infection were included, with a 133 median age of 3.6 years (IQR, 1.8-7.5 years); 1784 (52.3%) were males. Among these patients, 226 (7.1%) had a 134 proven bacterial co-infection. Streptococcus pneumoniae was the most frequent pathogens causing the bacterial 135 co-infection in 82(36.2%) cases, followed by Staphylococcus aureus in 55 (24.3%) cases and Pseudomonas 136 aeruginosa in 34 (15.0%) cases (Table S1 ). Eight children (3.5%) displayed two positive respiratory tract bacterial 137 cultures.
139
When the baseline characteristics and clinical outcomes of the H1N1 plus bacterial co-infection group were 140 compared, children in the H1N1-alone group were older, but this result was not significant (median age, 2.5 vs 2.4 141 years, p=0.197). Differences in gender or weight were not observed between the two groups; however, the 142 bacterial co-infection group showed significantly higher inpatient admission (14.3% vs 50.4%, p<0.001) and ICU 143 admission rates (2.6% vs 36.3%, p<0.001) than patients in the H1N1-alone group. The bacterial co-infection group 144 also required longer hospital stays (5 vs 10 days, p=0.003) than H1N1-alone group and thus had much higher 145 hospital costs (median hospital cost, 1213.2 vs 3467.3 RMB, p<0.001). Moreover, a higher in-hospital mortality 146 rate was noted for the bacterial co-infection group than the H1N1 alone group (0.1% vs 4.8%, p<0.001) ( Table 1 ). Serum PCT, CRP and WBC levels were analyzed to identify potential biomarkers that distinguished between 151 H1N1 infections and H1N1 and bacterial co-infections. The median serum PCT, CRP and WBC levels were all significantly higher in the H1N1 with bacterial co-infection group than in the H1N1-alone group (median PCT 153 level, 1.46 vs 0.21 ng/ml, p<0.001; median CRP level, 19.20 vs 5.10 mg/dl, p<0.001, median WBC count, 8.50 vs 154 6.90 ×10 9 cells/l, p=0.019) ( Figure 1 
148
Comparison of serum PCT, CRP and WBC levels between H1N1-alone and H1N1 with bacterial
197
The diagnostic utility of CRP to differentiate bacterial co-infection from H1N1 infection is disputed [9-11, 15].
198
Haran et al. [11] found that CRP as predictor of bacterial infection among patients with an H1N1 infection.
199
Similarly, Shin et al. [10] reported that serum CRP levels was significantly higher in patients with bacterial 200 co-infection compared to those infected with H1N1 alone. But other study suggested that CRP levels were unable 201 to distinguish bacterial co-infections from H1N1 infections [9] . Our study showed that serum CRP levels was 202 significantly higher in patients with bacterial co-infection compared to those infected H1N1 infection alone, it 203 indicating that those biomarkers could be aid in discriminating between these conditions. Furthermore, our study 204 showed that the diagnostic efficacy of PCT for bacterial co-infection in H1N1 infection was better than that of 205 CRP (AUC 0.801 and 0.783, respectively; p<0.05), consistent with the results of a previous study [11] . However, 206 the AUC of WBC counts in diagnosing bacterial co-infections was 0.551 (95%CI, 0.502-0.592), indicating that 207 WBC may not be a valuable biomarker for our cohort of children.
208
Previous study use of a combination of CRP and PCT levels for evaluating for bacterial co-infections increased the 
230
Furthermore, a significantly higher hospital mortality rate was observed in children with H1N1 and bacterial 231 co-infections because bacterial co-infections represent an important mortality risk factor, possibly suggesting early 232 empiric antibiotics treatment in severe patients may improve outcomes.
233
The potential limitations of our study should be mentioned. First, the levels of selected biomarkers (PCT, CRP and 234 WBC) were evaluated only once. Second, our diagnostic model was derived and validated at a single hospital 235 center, and it should be validated in a multicenter trial center before its broad application. Finally, we also 236 acknowledge that, we may have created a bias, due to bacterial organisms cannot be confirmed solely with blood, 237 sputum, lower respiratory tract samples.
239
Conclusion
240
In conclusion, we detected serum PCT and CRP levels and revealed that they represent promising biomarkers and 241 useful clinical tools for differentiating pediatric patients with bacterial co-infections from those infected with H1N1 alone. Furthermore, the combination of PCT and CRP levels could represent a useful method for screening 243 bacterial co-infections from H1N1 influenza infections alone in children during the early disease phase. After 244 further validation, the flexible model reported here may assist clinicians with decision-making processes. 
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Abbreviations: IQR: interquartile range; ICU: intensive care unit; * The differences between the H1N1-alone group and bacterial co-infection group were examined using the Wilcoxon rank sum test or Chi-square tests. In-hospital mortality, n (%) 3 (0.1) 11 (4.8) <0.001
359
Abbreviations: IQR: interquartile range; ICU: intensive care unit; * The differences between the H1N1-alone group and bacterial co-infection group were examined using the Wilcoxon rank sum test or Chi-square tests. 
